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To determine whether motion sickness induced by optokinetic stimulation would
trigger migraine-like attacks, 27 migraine sufferers and 23 controls attended the
laboratory up to three times at intervals of at least 3 weeks. On one occasion
subjects experienced up to 15 min of optokinetic stimulation, followed by three
30-s applications of ice to the temple at 4-min intervals. On another occasion, the
ice applications preceded and accompanied optokinetic stimulation. On a third
occasion, one hand was immersed in ice water for 30  s, three times at 4-min
intervals before and during optokinetic stimulation. Subjects recorded headache
activity in a diary over the course of the study. None of the controls experienced
a migraine-like attack at any stage of the experiment. In migraine sufferers, the
incidence of migraine-like attacks was greater than the expected daily incidence
of 8% after sessions that involved painful stimulation of the temple during or after
optokinetic stimulation (44% and 28% of the group, respectively) (P < 0.001). In
contrast, migraine-like attacks developed in only 13% of migraine sufferers after
the session that involved immersing the hand in ice water during optokinetic
stimulation (not signiﬁcant). The development of nausea and headache during
optokinetic stimulation increased the likelihood of migraine-like attacks after-
wards. These ﬁndings indicate that motion sickness and head pain increase sus-
ceptibility to migrainous attacks in migraine sufferers, and suggest that the
symptoms of migraine build upon each other in a vicious circle. Thus, targeting
multiple symptoms should be more effective than targeting individual symptoms,
both for preventing and treating attacks of migraine.  Headache, migraine, motion
sickness, nausea 
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Introduction
Motion sickness resembles migraine in several ways
– both are associated with vestibular disturbances,
nausea, vomiting, pallor and headache (1–6). Indeed,
heightened susceptibility to motion sickness in
migraine sufferers (5, 7–9) suggests some overlap of
mechanisms. Discharge of sensitized or disinhibited
trigeminal nociceptive neurons may increase suscep-
tibility to migraine (10–12) and augment headache
during attacks (13–15). Similarly, excitability in
brainstem emetic neurons might boost nausea in
migraine sufferers both during motion sickness (9,
16) and during attacks of migraine.
If similar mechanisms are involved in motion
sickness and migraine, then a bout of motion sick-
ness could increase the likelihood of an attack of
migraine. This possibility was investigated in sailors
competing in a ‘round the world’ yacht race (17, 18).
During the race, participants recorded the occur-
rence of motion sickness and characteristics of head-
ache in a daily log. Although sailors who suffered
from migraine during the race were more suscepti-
ble than other sailors to motion sickness, migraine
and motion sickness apparently developed at differ-
ent times. However, these ﬁndings are not deﬁnitive
because the participants may have had difﬁculty dis-
tinguishing between symptoms of motion sickness220 A Granston & PD Drummond
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and migraine in the presence of ongoing motion
sickness provocation.
The aim of the present study was to determine
whether migraine-like headaches would develop
after brief exposure to motion sickness provocation.
In particular, the incidence of prolonged headache
and nausea in migraine sufferers and controls was
investigated after exposure to the illusion of move-
ment induced by watching black and white stripes
move past (an optokinetic effect). As reported else-
where (9), the main goal of this research was to
determine whether painful stimulation of the head
would enhance nausea in migraine sufferers dur-
ing optokinetic stimulation. One of the sessions
involved applying an ice block to the temple (thus
inducing head pain) during optokinetic stimulation,
whereas the subject’s hand was immersed in pain-
fully cold ice water during optokinetic stimulation
in another session. In a third session ice was applied
to the temple after optokinetic stimulation, to deter-
mine whether head pain would inﬂuence residual
symptoms of motion sickness.
Subjects recorded details of their attacks in a head-
ache diary over the course of the study. It was
hypothesized that the incidence of migraine-like
attacks would be greater after optokinetic stimula-
tion than at other times during the recording period.
Since painful stimulation of the head might excite
the trigeminal nociceptive neurons that mediate
headache, it was also hypothesized that the incidence
of migraine-like attacks would be greater after opto-
kinetic stimulation accompanied by painful stimula-
tion of the head than after optokinetic stimulation
accompanied by painful stimulation of the hand.
Subjects and methods
Subjects
The migraine sample consisted of 22 women and ﬁve
men (mean age  ± SD,  40.7 ± 11.2 years;  range  20–
59 years) who met International Headache Society
criteria for migraine with aura (n =  3) or without
aura (n = 24) (19). Participants did not take prophy-
lactic medication for migraine and had no other
major medical conditions. The control group con-
sisted of 17 women and six men (mean age
39.7 ±  11.8  years; range 18–62  years) who reported
less than 12 headaches per year that did not meet
diagnostic criteria for migraine and that were
relieved by analgesics. Each participant provided
informed consent for the procedures, which were
approved by the Murdoch University Human
Research Ethics Committee.
Experiments were carried out when subjects were
free from headache for at least 4 days, and women
were tested between menstrual periods. All but four
migraine sufferers and one control subject attended
three sessions separated by at least 3  weeks. Two
migraine sufferers began prophylactic medication
after participating in one session and were not tested
further, and the other two withdrew from the exper-
iment after the ﬁrst session because of prolonged
headache and nausea. The control subject withdrew
because of time constraints.
Procedures
The procedures have been described in detail else-
where (9, 20). In brief, one session consisted of up to
15  min of optokinetic stimulation, followed about
20 min later by three 30-s applications of ice to the
temple at 4-min intervals (Fig. 1). On another occa-
sion, three ice applications preceded optokinetic
stimulation and another three applications accompa-
nied optokinetic stimulation at 4-min intervals. On a
third occasion, one hand was immersed in ice water
for 30 s, three times at 4-min intervals before and
during optokinetic stimulation. The session order
was counterbalanced across subjects.
Subjects were asked to record details of their head-
aches in a diary over the course of the study. The
number of days recorded depended on when the
subject returned for the ﬁnal session, and averaged
Figure 1 The sequence of procedures in the three sessions 
(a–c). In each session, the optokinetic stimulus lasted up to 
15 min. Ice was applied to the temple, or the hand was 
immersed in ice water at intervals shown by the arrows. (a) 
Optokinetic stimulation followed by ice on the temple. (b) Ice 
on the temple before and during optokinetic stimulation. (c) 
Hand in ice water before and during optokinetic stimulation.
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77 ± 27 days (mean ± SD) in migraine sufferers and
67 ± 15 days in controls. If the headache was rated as
more than mild (i.e. >3 on a 0–10 scale of intensity),
subjects were asked to record headache details (the
location of pain, treatment, and the presence of
symptoms such as photophobia, phonophobia, nau-
sea, vomiting, dizziness, sweating, drowsiness, and
aura) every 8  h until the headache subsided. The
accuracy of the diary recordings was checked each
time the subject attended the laboratory.
Data reduction
Since headache details generally were not recorded
consistently enough for diagnostic criteria to be
applied for migraine or probable migraine (19),
headaches were grouped into categories with or
without nausea and those with nausea are referred
to as migraine-like attacks. A rating of peak intensity
was obtained from the headache diary and the dura-
tion of attacks was estimated to the nearest half day.
Headaches on the day of testing either subsided
without drug treatment shortly after optokinetic
stimulation, or persisted for at least several hours
despite drug treatment. Since the aim of this study
was to determine whether optokinetic stimulation
would trigger migraine-like attacks, headaches that
subsided shortly after optokinetic stimulation were
not considered further. To estimate general headache
activity over the course of the study, the proportion
of days during the recording period with headaches,
with or without nausea, was calculated for each sub-
ject (excluding headaches that started during or
shortly after optokinetic stimulation).
Results
None of the control subjects experienced prolonged
headache or nausea after optokinetic stimulation.
One control subject experienced headache with nau-
sea at another time during the recording period, but
this attack was unlikely to be migraine because it
was associated with symptoms of upper respiratory
tract infection. Control subjects reported headaches
on only 1 ± 1% (mean ± SD) of days throughout the
recording period, compared with 25 ± 20% of days
in migraine sufferers [t(42)  = 5.57, P < 0.001]. Since
headache activity was minimal in control subjects,
their headache details were not included in the anal-
yses reported below.
A high incidence of headaches in a few migraine
sufferers disproportionately boosted the mean num-
ber of days of headache (deviation of the distribution
from normal, Kolmogorov–Smirnov Z  = 1.886,
P <  0.01 for headaches with nausea; and Kolmog-
orov–Smirnov Z  = 1.923,  P <  0.001 for headaches
without nausea). Therefore, the expected daily inci-
dence of headaches was based on the median rather
than the mean number of days with headache
throughout the recording period (excluding attacks
that started during or shortly after optokinetic
stimulation).
As shown in Table  1, 44% of migraine sufferers
experienced a migraine-like attack (prolonged mod-
erate or severe headache with nausea) after the
session involving application of ice to the temple
during optokinetic stimulation, compared with an
expected daily incidence of only 8% [c
2(1) = 42.6,
P < 0.001]. Similarly, the incidence of headache with
nausea exceeded the expected incidence after the
session involving application of ice to the temple
after optokinetic stimulation [28% vs. 8%, c
2(1) =
13.0,  P <  0.001]. Immersing the hand in ice water
during optokinetic stimulation boosted the rate of
headache without nausea [26% of cases vs. an
expected incidence of 11%, c
2(1) = 4.85, P < 0.05] but
not the rate of migraine-like attacks. In fact, head-
aches with nausea were less likely to develop after
Table 1 Percentage of migraine sufferers expected to experience headache on the day of the test, and the percentage who actually 
experienced a headache after each session
Headache
without nausea, %
Headache
with nausea, %
Expected daily incidence of headache 11 8
Incidence of headache after each session
Ice on the temple after optokinetic stimulation (n = 25) 16 28**
Ice on the temple before and during optokinetic stimulation (n = 25) 16 44**
Immersing the hand in ice water before and during optokinetic stimulation (n = 23) 26* 13†
Actual incidence greater than the expected incidence (*P < 0.05; **P < 0.001).
†Signiﬁcantly less than the 44% of migraine sufferers who developed headache with nausea after ice was applied to the temple
during optokinetic stimulation (McNemar test, P < 0.05).222 A Granston & PD Drummond
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the hand was immersed in ice water during optoki-
netic stimulation than after ice was applied to the
temple during optokinetic stimulation (13% vs. 44%;
McNemar test, P < 0.05).
The proportion of migraine sufferers who treated
their postsession headache with medication did not
differ signiﬁcantly across sessions (Table 2). Head-
aches lasted longer after sessions involving applica-
tion of ice to the temple than after the session
involving immersion of the hand in ice water
[2.6 ± 2.9 days  vs.  1.0 ± 1.1 days,  t(32) = 2.38,  P <
0.05]. However, neither the timing of application of
ice to the temple (i.e. during vs. after optokinetic
stimulation) nor the site of painful stimulation (tem-
ple vs. hand) affected the intensity of postsession
headaches (Table 3).
As shown in Table  4, the presence of nausea
and/or headache during optokinetic stimulation
increased the likelihood of prolonged headache in
migraine sufferers after the session. The number
of symptoms during optokinetic stimulation was
proportional to the number of symptoms after-
wards for sessions that involved applying ice to
the temple during optokinetic stimulation (Spear-
man’s  r = 0.47,  P <  0.05) and immersing the hand
in ice water during optokinetic stimulation
(Spearman’s  r = 0.63,  P <  0.001); a similar relati-
onship for the session that involved applying ice
to the temple after optokinetic stimulation did
not achieve statistical signiﬁcance (Spearman’s
r = 0.29).
Discussion
Painful stimulation of the temple during and after
optokinetic stimulation boosted the incidence of
migraine-like attacks in migraine sufferers, and
painful stimulation of the hand during optokinetic
stimulation boosted the incidence of headaches
without nausea. In contrast, none of the control sub-
jects experienced migraine-like attacks after optoki-
netic stimulation or at any other time over the course
of the study.
We previously reported that the immediate effects
of optokinetic stimulation and painful stimulation of
the temple and hand differed between migraine suf-
ferers and controls. In particular, nausea and head-
ache were greater in migraine sufferers than controls
during optokinetic stimulation (9, 16), and could be
aggravated by painful stimulation of the temple but
not the hand (9). In general, migraine sufferers are
more susceptible than controls to gastrointestinal
disturbances (5, 7–9, 21–24) and photophobia (25–29)
during the headache-free period, suggesting that the
migraine mechanism persists subclinically between
attacks.
Migraine sufferers who experienced nausea and
headache during optokinetic stimulation were more
likely to experience migraine-like attacks afterwards
than migraine sufferers who did not develop nausea
or headache during optokinetic stimulation. This
association was not perfect – symptoms of motion
sickness invariably resolved quickly after optoki-
Table 2 Percentage of migraine sufferers who treated their attack after each session
Ice on the temple after
optokinetic stimulation, %
(n = 25)
Ice on the temple before
and during optokinetic 
stimulation, % (n = 25)
Immersing the hand in ice water 
before and during optokinetic 
stimulation, % (n = 23)
No headache 56 40 61
Headache (untreated) 16 24 26
Headache (treated) 28 36 13
The incidence of headache treatment did not differ signiﬁcantly across the three experimental conditions.
Table 3 Intensity and duration of postsession headaches for migraine sufferers who experienced those headaches
Mean ± SD
Ice on the temple after
optokinetic stimulation
(n = 11 of 25)
Ice on the temple before
and during optokinetic
stimulation (n = 15 of 25)
Immersing the hand in ice water 
before and during optokinetic 
stimulation (n = 9 of 23)
Intensity (0–10) 5.6 ± 2.9 4.8 ± 2.4 3.6 ± 2.5
Duration (days) 2.6 ± 3.1 2.6 ± 2.8 1.0 ± 1.1Motion sickness and migraine 223
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netic stimulation in controls and only sometimes
developed into a migraine-like attack in migraine
sufferers. Nevertheless, the incidence of these
attacks far exceeded the median daily incidence of
headaches, implying that a short period of motion
sickness sometimes triggered a prolonged attack of
migraine.
Painful stimulation of the temple during and after
optokinetic stimulation boosted the incidence of
migraine-like attacks, presumably because trigemi-
nal nerve discharge enhanced the provocative effect
of motion sickness on the migraine mechanism. In
contrast, painful stimulation of the hand boosted the
incidence of headaches without nausea but not of
migraine-like attacks. It is interesting to note that
nausea and headache increased during painful stim-
ulation of the temple but not during painful stimu-
lation of the hand (9, 20). These ﬁndings support the
notion that trigeminal nerve discharge and nausea
build upon each other in a positive loop, sometimes
culminating in an attack of migraine. In contrast,
painful stimulation of the hand before and during
optokinetic stimulation boosted the incidence of
non-migrainous attacks, possibly due to the stressful
nature of the tasks. Painful stimulation of the hand
during optokinetic stimulation might also have
provoked a modulatory effect (e.g. stress-induced
analgesia or diffuse noxious inhibitory controls)
that inhibited the full expression of migrainous
symptoms.
In conclusion, the ﬁndings indicate that motion
sickness and head pain increase susceptibility to
migraine-like  attacks  in  migraine  sufferers  but
not controls, presumably because the provocation
threshold for migrainous symptoms is lower in
migraine sufferers than in controls. The ﬁndings also
support the notion that symptoms of migraine build
upon each other in a vicious circle. If so, targeting
multiple symptoms (e.g. headache, gastrointestinal
complaints, and disturbances of the special senses)
should be more effective than targeting individual
symptoms, both for preventing and treating attacks
of migraine.
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